• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

无信号传导趋化因子受体:作用机制及体内作用

Non-signaling chemokine receptors: mechanism of action and role in vivo.

作者信息

Bonecchi Raffaella, Borroni Elena M, Savino Benedetta, Buracchi Chiara, Mantovani Alberto, Locati Massimo

机构信息

Istituto Clinico Humanitas, IRCCS Via Manzoni 113, I-20089 Rozzano, Milan, Italy.

出版信息

J Neuroimmunol. 2008 Jul 31;198(1-2):14-9. doi: 10.1016/j.jneuroim.2008.04.018. Epub 2008 Jun 2.

DOI:10.1016/j.jneuroim.2008.04.018
PMID:18513804
Abstract

Cell migration is fundamental for numerous biological processes and is critical for the pathogenesis of several diseases. Chemokines represent the main class of mediators providing cell directional migration and several levels of regulation of their function have been identified. A subfamily of chemokine receptors not able to transduce chemotactic signals plays an important role in the control of chemokine concentrations through binding, internalization and degradation of chemotactic factors. Here we review in vitro and in vivo evidences indicating that these 'silent' chemokine receptors represent a strategy to regulate innate and adaptive immunity.

摘要

细胞迁移是众多生物学过程的基础,对多种疾病的发病机制至关重要。趋化因子是提供细胞定向迁移的主要一类介质,并且已经确定了其功能的多个调控水平。一类无法转导趋化信号的趋化因子受体亚家族,通过趋化因子的结合、内化和降解,在控制趋化因子浓度方面发挥重要作用。在此,我们综述了体外和体内的证据,表明这些“沉默”的趋化因子受体是调节先天性免疫和适应性免疫的一种策略。

相似文献

1
Non-signaling chemokine receptors: mechanism of action and role in vivo.无信号传导趋化因子受体:作用机制及体内作用
J Neuroimmunol. 2008 Jul 31;198(1-2):14-9. doi: 10.1016/j.jneuroim.2008.04.018. Epub 2008 Jun 2.
2
Tuning inflammation and immunity by chemokine sequestration: decoys and more.通过趋化因子隔离调节炎症和免疫:诱饵及其他方法
Nat Rev Immunol. 2006 Dec;6(12):907-18. doi: 10.1038/nri1964.
3
Chemokine sequestration by atypical chemokine receptors.非典型趋化因子受体对趋化因子的隔离作用
Biochem Soc Trans. 2006 Dec;34(Pt 6):1009-13. doi: 10.1042/BST0341009.
4
Post-translational control of chemokines: a role for decoy receptors?趋化因子的翻译后调控:诱饵受体的作用?
Immunol Lett. 2005 Jan 31;96(2):163-74. doi: 10.1016/j.imlet.2004.08.018.
5
Regulation of chemotactic networks by 'atypical' receptors.“非典型”受体对趋化网络的调控
Bioessays. 2007 Mar;29(3):237-47. doi: 10.1002/bies.20537.
6
Chemokines and chemokine receptors in the brain: implication in neuroendocrine regulation.大脑中的趋化因子与趋化因子受体:对神经内分泌调节的影响
J Mol Endocrinol. 2007 Mar;38(3):355-63. doi: 10.1677/JME-06-0035.
7
An apparent paradox: chemokine receptor agonists can be used for anti-inflammatory therapy.一个明显的悖论:趋化因子受体激动剂可用于抗炎治疗。
Mol Immunol. 2007 Mar;44(7):1477-82. doi: 10.1016/j.molimm.2006.08.011. Epub 2006 Sep 26.
8
Relationships between glycosaminoglycan and receptor binding sites in chemokines-the CXCL12 example.趋化因子中糖胺聚糖与受体结合位点之间的关系——以CXCL12为例
Carbohydr Res. 2008 Aug 11;343(12):2018-23. doi: 10.1016/j.carres.2008.01.047. Epub 2008 Feb 20.
9
The role of chemokines and their receptors in ocular disease.趋化因子及其受体在眼部疾病中的作用。
Prog Retin Eye Res. 2004 Jul;23(4):435-48. doi: 10.1016/j.preteyeres.2004.04.004.
10
Regulation of chemokine activity by posttranslational modification.通过翻译后修饰对趋化因子活性的调控。
Pharmacol Ther. 2008 Nov;120(2):197-217. doi: 10.1016/j.pharmthera.2008.08.006. Epub 2008 Aug 28.

引用本文的文献

1
New pairings and deorphanization among the atypical chemokine receptor family - physiological and clinical relevance.新型趋化因子受体家族配体及其孤儿受体的鉴定——生理和临床相关性。
Front Immunol. 2023 Apr 20;14:1133394. doi: 10.3389/fimmu.2023.1133394. eCollection 2023.
2
The Pretreatment Neutrophil/Lymphocyte Ratio Is Associated with All-Cause Mortality in Black and White Patients with Non-metastatic Breast Cancer.治疗前中性粒细胞/淋巴细胞比值与非转移性乳腺癌黑种人和白种患者的全因死亡率相关。
Front Oncol. 2016 Mar 31;6:81. doi: 10.3389/fonc.2016.00081. eCollection 2016.
3
Neutralizing endogenous chemokines with small molecules. Principles and potential therapeutic applications.
用小分子中和内源性趋化因子。原理和潜在的治疗应用。
Pharmacol Ther. 2010 Apr;126(1):39-55. doi: 10.1016/j.pharmthera.2009.12.003. Epub 2010 Feb 1.
4
Effects of PARP-1 deficiency on airway inflammatory cell recruitment in response to LPS or TNF: differential effects on CXCR2 ligands and Duffy Antigen Receptor for Chemokines.PARP-1缺乏对响应脂多糖或肿瘤坏死因子时气道炎性细胞募集的影响:对CXCR2配体和趋化因子达菲抗原受体的不同影响。
J Leukoc Biol. 2009 Dec;86(6):1385-92. doi: 10.1189/jlb.0309183. Epub 2009 Sep 10.
5
Reduced neutrophil count in people of African descent is due to a regulatory variant in the Duffy antigen receptor for chemokines gene.非洲裔人群中性粒细胞计数减少是由于趋化因子基因的达菲抗原受体中的一个调控变异。
PLoS Genet. 2009 Jan;5(1):e1000360. doi: 10.1371/journal.pgen.1000360. Epub 2009 Jan 30.